Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec versus insulin detemir in children and adolescents with type 1 diabetes
2011-003148-39Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diabetes mellitus type 1 (T1D) comparing Insulin degludec + insulin aspart with Insulin detemir + insulin aspart (2 arms). Primary endpoint: Change from baseline in HbA1c after 26 weeks. Started Oct 2011; status: completed.
02
Drugs
insulin degludecinsulin detemirinsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2011-003148-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003148-39.